fda novavax - Search News

Order byBest matchMost fresh

Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

The approval positions Novavax as the only non-mRNA COVID-19 vaccine with full FDA approval, offering a differentiated alternative amid growing mRNA fatigue.

· 17h

Infectious Disease Advisor · 15h

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

· 2d · on MSN

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

WA vaccine scientists push back against FDA changes around COVID shots

Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

· 16h

· 1d

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

FDA sets new COVID booster guidelines for healthy adults under 65

Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

· 1d

Trump officials set new requirements for COVID vaccines in healthy adults and children

· 1d

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

1don MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

4don MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness.

2don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.